Killing Lymphoma with Smac-Mimetics: As Easy as ABC?

Slides:



Advertisements
Similar presentations
Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Advertisements

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
A Novel Link between Inflammation and Cancer
Smac Mimetics and TNFα: A Dangerous Liaison?
A Nurr1 Pathway for Neuroprotection
NF-κB: A Coordinator for Epigenetic Regulation by MLL
Intravascular Survival and Extravasation of Tumor Cells
Kenneth L. Scott, Scott Powers  Cancer Cell 
Nomeda Girnius, Roger J. Davis  Cancer Cell 
IRS-1: Auditing the effectiveness of mTOR inhibitors
Volume 29, Issue 4, Pages (April 2016)
Another Piece of the p27Kip1 Puzzle
Radiotherapy Complements Immune Checkpoint Blockade
Antagonizing ClpP: A New Power Play in Targeted Therapy for AML
Nuclear Factor-κB Pathway–Activating Gene Aberrancies in Primary Cutaneous Large B-Cell Lymphoma, Leg Type  Lianne Koens, Willem H. Zoutman, Passorn Ngarmlertsirichai,
Data Triumph at C Cancer Cell
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Notch: Filling a Hole in T Helper 2 Cell Differentiation
Whipping NF-κB to Submission via GADD45 and MKK7
Cell signaling and cancer
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Polycomb Regulates NF-κB Signaling in Cancer through miRNA
Methed-Up FOXOs Can't In-Akt-ivate
Xenobiotic receptor meets NF-κB, a collision in the small bowel
The Two Faces of Receptor Interacting Protein Kinase-1
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
Proteaphagy—Selective Autophagy of Inactive Proteasomes
Volume 46, Issue 5, Pages (June 2012)
Characterizing the Killer Colorectal Carcinomas
IRS-1: Auditing the effectiveness of mTOR inhibitors
A New “Brew” of MALT1 Inhibitors
Richard G. Carroll, Seamus J. Martin  Cancer Cell 
Volume 28, Issue 5, Pages (November 2015)
Connecting Mitochondria and Innate Immunity
miR-34a and the Cardiomyopathy of Senescence: SALT PNUTS, SALT PNUTS!
Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome 
FAL1ing inside an Amplicon
Dampening NF-κB Signaling by “Self-Eating”
14-3-3ζ Turns TGF-β to the Dark Side
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
TIGIT and CD226: Tipping the Balance between Costimulatory and Coinhibitory Molecules to Augment the Cancer Immunotherapy Toolkit  Kristen E. Pauken,
Powering Reprogramming with Vitamin C
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
Negative Feedback Mechanisms and Their Roles during Pattern Formation
Kenneth L. Scott, Scott Powers  Cancer Cell 
Dolors Colomer, Elías Campo  Cancer Cell 
NO Signals from the Cancer Stem Cell Niche
Volume 19, Issue 5, Pages (September 2005)
Bacterial Interference of Ubiquitination and Deubiquitination
DUB-le Trouble for Cell Survival
Antigen-Receptor Signaling to Nuclear Factor κB
Volume 22, Issue 6, Pages (February 2018)
Wilbert Bitter, Coen Kuijl  Cell Host & Microbe 
A possible mechanism of renal cell death after ischemia/reperfusion
Shared Principles in NF-κB Signaling
Sticking It to Cancer with Molecular Glue for SHP2
Role reversal: Brain insulin and liver STAT3
Sam68 Guest STARs in TNF-α Signaling
Volume 4, Issue 4, Pages (April 2009)
FAL1ing inside an Amplicon
All Roads Lead to the Ribosome
The TRIP from ULF to ARF Cancer Cell
Apoptosis: Activate NF-κB or die?
The Dopamine D2 Receptor: New Surprises from an Old Friend
TAMpering with Toll-like Receptor Signaling
The Tribble with APL: A New Road to Therapy
Connecting with an Old Partner in a New Way
Skp2, the FoxO1 hunter Cancer Cell
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

Killing Lymphoma with Smac-Mimetics: As Easy as ABC? Ueli Nachbur, John Silke  Cancer Cell  Volume 29, Issue 4, Pages 425-427 (April 2016) DOI: 10.1016/j.ccell.2016.03.018 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Schematic Indicating Multiple Roles of cIAPs in Regulating Signaling Pathways (A) cIAPs regulate multiple signaling pathways by building K63-linked ubiquitin chains. Yang et al. show that they also perform this same function in CARMA-Bcl10-MALT1 signaling. Red text: key molecules and concepts described in Yang et al. cIAPs are also required to inhibit the activation of non-canonical NF-κB by targeting NIK for proteasomal degradation by the addition of K48-linked ubiquitin chains. (B) Birinapant promotes auto-ubiquitylation and proteosomal degradation of cIAPs, thereby preventing the B cell receptor signaling survival and activating non-canonical NF-κB. A role for TNF-induced death was not explored in Yang et al. but may contribute to cell death. Cancer Cell 2016 29, 425-427DOI: (10.1016/j.ccell.2016.03.018) Copyright © 2016 Elsevier Inc. Terms and Conditions